Australia
It will be used to test implants for hip and knee replacements.
The new funds will go toward further scaling its platform in the United States.
It is currently conducting clinical studies and expanding its teams in Australia and the US.
It claims to help people stop smoking in four weeks.
It is a home-based programme with 10 self-paced modules.
The company also has pending approvals for the device in Australia and Thailand.
The online treatment has been licensed to Blue Note Therapeutics for the development of a counterpart version in North America.
It also plans to double its headcount over the next 12 months.
It has also entered into a collaboration with The Pharmacy Guild of Australia for health service initiatives.
It has been approved as a prescription-only software-as-a-medical device in the US.